BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coron E, Hatlebakk JG, Galmiche JP. Medical therapy of gastroesophageal reflux disease. Curr Opin Gastroenterol. 2007;23:434-439. [PMID: 17545782 DOI: 10.1097/mog.0b013e328159f001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Wehling M. Assessing the translatability of drug projects: what needs to be scored to predict success? Nat Rev Drug Discov 2009;8:541-6. [PMID: 19543224 DOI: 10.1038/nrd2898] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 6.8] [Reference Citation Analysis]
2 Dickman R, Boaz M, Aizic S, Beniashvili Z, Fass R, Niv Y. Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil 2011;17:387-94. [PMID: 22148108 DOI: 10.5056/jnm.2011.17.4.387] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
3 Fockens P, Cohen L, Edmundowicz SA, Binmoeller K, Rothstein RI, Smith D, Lin E, Nickl N, Overholt B, Kahrilas PJ, Vakil N, Abdel Aziz Hassan AM, Lehman GA. Prospective randomized controlled trial of an injectable esophageal prosthesis versus a sham procedure for endoscopic treatment of gastroesophageal reflux disease. Surg Endosc 2010;24:1387-97. [PMID: 20198491 DOI: 10.1007/s00464-009-0784-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
4 Kusano M, Hosaka H, Kawamura O, Kawada A, Kuribayashi S, Shimoyama Y, Yasuoka H, Mizuide M, Tomizawa T, Sagawa T, Sato K, Yamada M. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy. J Gastroenterol 2015;50:298-304. [PMID: 24919745 DOI: 10.1007/s00535-014-0972-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Dickman R, Maradey-Romero C, Gingold-Belfer R, Fass R. Unmet Needs in the Treatment of Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2015;21:309-19. [PMID: 26130628 DOI: 10.5056/jnm15105] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
6 Aziz AM, El-Khayat HR, Sadek A, Mattar SG, McNulty G, Kongkam P, Guda MF, Lehman GA. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24:818-825. [PMID: 19730952 DOI: 10.1007/s00464-009-0671-4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
7 Zhu Q, Liu WZ. Advances in roles of prokinetic agents in the treatment of gastroesophageal reflux disease. Shijie Huaren Xiaohua Zazhi 2008; 16(7): 737-745 [DOI: 10.11569/wcjd.v16.i7.737] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Hamdy E, El Nakeeb A, Hamed H, El Hemaly M, ElHak NG. Outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease in non-responders to proton pump inhibitors. J Gastrointest Surg. 2014;18:1557-1562. [PMID: 24985244 DOI: 10.1007/s11605-014-2584-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
9 Yang L, Cai H, Tou J, Gu W, Shu X, Zhang T, Yang X, Shen Z, Jiang M. The role of the 5-hydroxytryptamine pathway in reflux-induced esophageal mucosal injury in rats. World J Surg Oncol. 2012;10:219. [PMID: 23092450 DOI: 10.1186/1477-7819-10-219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
10 Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev. 2011;CD004823. [PMID: 21249664 DOI: 10.1002/14651858.cd004823.pub4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]